XML 19 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Stockholders' Equity          
Beginning balance $ 665,471 $ 20 $ 1,195,390 $ (1,658) $ (528,281)
Beginning balance (in shares) at Dec. 31, 2024   200,535,000      
Stockholders' Equity          
Issuance of common stock in connection with ESPP (in shares)   497,000      
Issuance of common stock in connection with ESPP 5,768   5,768    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)   2,793,000      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 2,392   2,392    
Donation of common stock (in shares)   45,000      
Donation of common stock 959   959    
Taxes paid related to net share settlement of equity awards (in shares)   (44,000)      
Taxes paid related to net shares settlement of equity awards (1,089)   (1,089)    
Stock-based compensation expense 36,890   36,890    
Other comprehensive income (loss) 1,733     1,733  
Net income (loss) 11,352       11,352
Ending balance (in shares) at Mar. 31, 2025   203,826,000      
Ending balance at Mar. 31, 2025 $ 723,476 $ 20 1,240,310 75 (516,929)
Beginning balance (in shares) at Dec. 31, 2024   200,535,000      
Stockholders' Equity          
Common stock repurchased (in shares) 0        
Net income (loss) $ 17,888        
Ending balance (in shares) at Jun. 30, 2025   206,091,000      
Ending balance at Jun. 30, 2025 764,922 $ 21 1,271,110 4,184 (510,393)
Stockholders' Equity          
Beginning balance 723,476 $ 20 1,240,310 75 (516,929)
Beginning balance (in shares) at Mar. 31, 2025   203,826,000      
Stockholders' Equity          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)   2,739,000      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 2,187 $ 1 2,186    
Donation of common stock (in shares)   46,000      
Donation of common stock 907   907    
Taxes paid related to net share settlement of equity awards (in shares)   (520,000)      
Taxes paid related to net shares settlement of equity awards (11,589)   (11,589)    
Stock-based compensation expense 39,296   39,296    
Other comprehensive income (loss) 4,109     4,109  
Net income (loss) 6,536       6,536
Ending balance (in shares) at Jun. 30, 2025   206,091,000      
Ending balance at Jun. 30, 2025 764,922 $ 21 1,271,110 4,184 (510,393)
Stockholders' Equity          
Beginning balance 764,922 21 1,271,110 4,184 (510,393)
Beginning balance 868,789 $ 21 1,325,520 3,596 (460,348)
Beginning balance (in shares) at Dec. 31, 2025   210,626,000      
Stockholders' Equity          
Issuance of common stock in connection with ESPP (in shares)   513,000      
Issuance of common stock in connection with ESPP 6,340   6,340    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)   1,978,000      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 417   417    
Donation of common stock (in shares)   45,000      
Donation of common stock 765   765    
Taxes paid related to net share settlement of equity awards (in shares)   (59,000)      
Taxes paid related to net shares settlement of equity awards (952)   (952)    
Common stock repurchased (in shares)   (2,770,000)      
Common stock repurchased (44,249)   (44,249)    
Stock-based compensation expense 28,439   28,439    
Other comprehensive income (loss) (1,162)     (1,162)  
Net income (loss) 49,053       49,053
Ending balance (in shares) at Mar. 31, 2026   210,333,000      
Ending balance at Mar. 31, 2026 $ 907,440 $ 21 1,316,280 2,434 (411,295)
Beginning balance (in shares) at Dec. 31, 2025   210,626,000      
Stockholders' Equity          
Common stock repurchased (in shares) (3,900,000)        
Common stock repurchased $ (65,600)        
Net income (loss) 254,961        
Ending balance (in shares) at Jun. 30, 2026   211,671,000      
Ending balance at Jun. 30, 2026 1,126,848 $ 21 1,329,975 2,239 (205,387)
Stockholders' Equity          
Beginning balance 907,440 $ 21 1,316,280 2,434 (411,295)
Beginning balance (in shares) at Mar. 31, 2026   210,333,000      
Stockholders' Equity          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)   2,532,000      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 1,034   1,034    
Donation of common stock (in shares)   46,000      
Donation of common stock 957   957    
Taxes paid related to net share settlement of equity awards (in shares)   (128,000)      
Taxes paid related to net shares settlement of equity awards (2,775)   (2,775)    
Common stock repurchased (in shares)   (1,112,000)      
Common stock repurchased (21,315)   (21,315)    
Stock-based compensation expense 35,794   35,794    
Other comprehensive income (loss) (195)     (195)  
Net income (loss) 205,908       205,908
Ending balance (in shares) at Jun. 30, 2026   211,671,000      
Ending balance at Jun. 30, 2026 1,126,848 $ 21 1,329,975 2,239 (205,387)
Stockholders' Equity          
Beginning balance $ 1,126,848 $ 21 $ 1,329,975 $ 2,239 $ (205,387)